Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Advani Hotels & Resorts (India) Limited reports Q1 FY20 results

Posted On: 2019-08-13 20:02:35

Advani Hotels and Resorts (India) Ltd, which owns and operates the 201-key, 5-star deluxe hotel, known as the 'Caravela Beach Resort Goa' that is situated on a 23-acre estate in South Goa, has approved the unaudited financial results at their Board Meeting held on August 13, 2019.

In the quarter ended June 30, 2019, the Company reported a Total Net Revenue of INR 1657 Lakhs, as compared to INR 1525 Lakhs, which reflects an 8. 7% growth in sales over the same period last year.

The Gross Operating Profit for this quarter grew to Rs. 309 Lakhs from Rs 228 Lakhs, reflecting a growth of 35.5%.

This was achieved by recording 84.7% average occupancy in the month of April, 84.7% occupancy in May and 90.9% occupancy in the month of June 2019.

The Average Net Revenue Per Occupied Room Per Night grew by 8.1% in April to Rs. 11 ,124 per room per night, grew by 12.1% in May toRs. 10,923 per room per night, and grew by 3.7% in June toRs. 9,594 per room per night.

The Profit Before Tax for the three months ended June 30, 2019 also grew to INR 216 Lakhs, as compared to INR 134 Lakhs, which reflects a 61.2% increase over the same period last year.

The Caravela Beach Resort Goa has also won several guest satisfaction awards in this quarter including:

- The Trip Advisor 'Certificate of Excellence' Award in May 2019, for the consistent achievement of high ratings from travelers, with over 3600 total guest reviews, yielding an average of 4.5 stars out of a maximum of 5.0 stars.

- An award certificate from the CEO of 'HolidayCheck AG' Germany in April 2019, with an average guest satisfaction score of 5.6 stars (out of a maximum of 6.0 stars).

- The Resort recently won the 'Best Employer Brand Award 2019' in Goa State, and also won the 'Best Recreational Resort' in the 5-Star hotel category by Holiday Biz.

Shares of ADVANI HOTELS & RESORTS (INDIA) LTD. was last trading in BSE at Rs.53.95 as compared to the previous close of Rs. 55.25. The total number of shares traded during the day was 207 in over 43 trades.

The stock hit an intraday high of Rs. 55.9 and intraday low of 53.9. The net turnover during the day was Rs. 11335.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Vanta Bioscience's facility gets NABL Accreditation

Karnataka Bank reports fraud by Hanung Toys and Textiles Ltd

HCL delivers powerful new value for 10 million Domino Applications Worldwide

Hindalco Industries Limited launches India's first All-Aluminium freight trailer

United Drilling Tools to get order from Halliburton Offshore Services Inc

Tata Power JV acquires 75.01% stake in Prayagraj Power Generation Company Ltd

Bharti Airtel Ltd proposes to raise $3 billion

Vaibhav Global Announces Completion of Buyback of its Equity Shares

SBI to divest its stake in UTI AMC through IPO

Lease agreement of Mount Shivalik Industries Ltd ends for running restaurant at Amer Fort

Artson Engineering Ltd receives order for Rs. 6.30 crores

India's largest kitchen appliance company TTK Prestige unveils 2020 plans

Shilpa Medicare gets EIR from US FDA for Raichur API unit

TCS Helps Ayala Land Digitally Transform its Finance Function

Ramco Systems FZ-LLC, Dubai secures 5 year order

Intellect Launches RM Office 2020 for Wealth Managers

GAIL awarded as the 'Project Management Company of the Year' 2019 by Hon'ble Minister of Petroleum & Natural Gas and Steel

Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection 3.5 mg/vial for Intravenous use only in the U.S. Market

L&T Construction bags new contracts for its various businesses

OnMobile collaborates with Samsung to build and manage its Contests ecosystem

Strides receives USFDA tentative approval for Diclofenac Potassium Softgel Capsules

CSB Bank Ltd reappoints MD & CEO

Vakrangee to launch India's First Rural Focussed Loyalty Program for its customers

Current Patent Laws are Inadequate for AI-related IP: New TCS Report

Caplin Steriles gets US FDA approval for Sodium Nitroprusside Injection

CARE reaffirms CP rating of Future Consumer Ltd

Eris Lifesciences Ltd announces acquisition of trademark- Zomelis together with its associated trademarks

Frontline Corporation Ltd commissions fuel pump as franchisee of Nayra Energy Ltd

NITCO Ltd Enters into Non-binding Term Sheet with Hines India Real Estate Pvt. Ltd.

OTS proposal of Sudal Industries Ltd Sanctioned

IRDAI approves True North's stake purchase in Max Bupa Health Insurance from Max India

ICRA revises ratings of IFCI Ltd

Offer for Sale of Shares by Promoters of HDFC Asset Management Company Ltd

NESTLE India Ltd board declares third interim dividend of Rs. 55

Steel Strips Wheels Ltd achieves total wheel rim sales of 12.52 lacs in November 2019

Wipro announces Advanced Cloud SOC Service Powered by Microsoft Azure Sentinel

Biocon Biologics Takes Forward Its Mission to Unlock Universal Access to Insulins Globally

HGS AxisPoint Health's Person-Centered Population Health Approach Receives Population Health Program Accreditation by NCQA

Paushak gets Responsible Care logo

NATCO Pharma Ltd completes investment in OMRV Hospitals Pvt Ltd

Lupin Foundation Wins Award for Excellence in Corporate Social Responsibility at India Pharma Awards 2019

Ultracab (India) Ltd receives order from MSEDCL for Rs. 23.69 crore

New Study by TCS: German Companies Have Sharply Hiked Spending on Digital Transformation

Zydus receives tentative approval from the USFDA for Lorcaserin Hydrochloride Tablets

Siddharth Mittal Takes Over as CEO and Joint Managing Director of Biocon Limited

Maruti Suzuki India Ltd to increase price of vehicles from January 2020

Lupin Wins Award for Operational Excellence in Manufacturing at India Pharma Awards 2019

Thomas Cook India signs an agreement to acquire the rights to the Thomas Cook Brand for the India, Sri Lanka & Mauritius markets

Biocon and Mylan Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S.

Tata Motors bags orders to supply over 2300 buses to various State Transport Undertakings







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019